TY - JOUR
T1 - MobiliSense cohort study protocol
T2 - do air pollution and noise exposure related to transport behaviour have short-term and longer-term health effects in Paris, France?
AU - Chaix, Basile
AU - Bista, Sanjeev
AU - Wang, Limin
AU - Benmarhnia, Tarik
AU - Dureau, Clélie
AU - Duncan, Dustin T.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/3/31
Y1 - 2022/3/31
N2 - INTRODUCTION: MobiliSense explores effects of air pollution and noise related to personal transport habits on respiratory and cardiovascular health. Its objectives are to quantify the contribution of personal transport/mobility to air pollution and noise exposures of individuals; to compare exposures in different transport modes; and to investigate whether total and transport-related personal exposures are associated with short-term and longer-term changes in respiratory and cardiovascular health. METHODS AND ANALYSIS: MobiliSense uses sensors of location, behaviour, environmental nuisances and health in 290 census-sampled participants followed-up after 1/2 years with an identical sensor-based strategy. It addresses knowledge gaps by: (1) assessing transport behaviour over 6 days with GPS receivers and GPS-based mobility surveys; (2) considering personal exposures to both air pollution and noise and improving their characterisation (inhaled doses, noise frequency components, etc); (3) measuring respiratory and cardiovascular outcomes (smartphone-assessed respiratory symptoms, lung function with spirometry, resting blood pressure, ambulatory brachial/central blood pressure, arterial stiffness and heart rate variability) and (4) investigating short-term and longer-term (over 1-2 years) effects of transport. ETHICS AND DISSEMINATION: The sampling and data collection protocol was approved by the National Council for Statistical Information, the French Data Protection Authority and the Ethical Committee of Inserm. Our final aim is to determine, for communicating with policy-makers, how scenarios of changes in personal transport behaviour affect individual exposure and health.
AB - INTRODUCTION: MobiliSense explores effects of air pollution and noise related to personal transport habits on respiratory and cardiovascular health. Its objectives are to quantify the contribution of personal transport/mobility to air pollution and noise exposures of individuals; to compare exposures in different transport modes; and to investigate whether total and transport-related personal exposures are associated with short-term and longer-term changes in respiratory and cardiovascular health. METHODS AND ANALYSIS: MobiliSense uses sensors of location, behaviour, environmental nuisances and health in 290 census-sampled participants followed-up after 1/2 years with an identical sensor-based strategy. It addresses knowledge gaps by: (1) assessing transport behaviour over 6 days with GPS receivers and GPS-based mobility surveys; (2) considering personal exposures to both air pollution and noise and improving their characterisation (inhaled doses, noise frequency components, etc); (3) measuring respiratory and cardiovascular outcomes (smartphone-assessed respiratory symptoms, lung function with spirometry, resting blood pressure, ambulatory brachial/central blood pressure, arterial stiffness and heart rate variability) and (4) investigating short-term and longer-term (over 1-2 years) effects of transport. ETHICS AND DISSEMINATION: The sampling and data collection protocol was approved by the National Council for Statistical Information, the French Data Protection Authority and the Ethical Committee of Inserm. Our final aim is to determine, for communicating with policy-makers, how scenarios of changes in personal transport behaviour affect individual exposure and health.
KW - Cardiac Epidemiology
KW - EPIDEMIOLOGY
KW - PUBLIC HEALTH
UR - http://www.scopus.com/inward/record.url?scp=85127452813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127452813&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2021-048706
DO - 10.1136/bmjopen-2021-048706
M3 - Article
C2 - 35361634
AN - SCOPUS:85127452813
SN - 2044-6055
VL - 12
SP - e048706
JO - BMJ open
JF - BMJ open
IS - 3
ER -